ERCC1 measurements in clinical oncology

被引：30

作者：

Reed, Eddie ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 10期

关键词：

D O I：

10.1056/NEJMe068162

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1054 / 1055

页数：2

共 12 条

[1]

[Anonymous], CANC CHEMOTHERAPY BI

[2] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].

Le Chevalier, T ;

Arriagada, R ;

Le Péchoux, C ;

Grunenwald, D ;

Dunant, A ;

Pignon, JP ;

Tarayre, M ;

Abratt, R ;

Arriagada, R ;

Bergman, B ;

Gralla, R ;

Grunenwald, D ;

Le Chevalier, T ;

Orlowski, T ;

Papadakis, E ;

Pinel, MIS ;

Araujo, C ;

Della Torre, H ;

de Solchaga, MM ;

Abdi, E ;

Blum, R ;

Ball, D ;

Basser, R ;

De Boer, R ;

Bishop, J ;

Brigham, B ;

Davis, S ;

Fox, D ;

Richardson, G ;

Wyld, D ;

Pirker, R ;

Humblet, Y ;

Delaunois, L ;

Van Meerbeeck, JP ;

Germonpre, P ;

Vansteenkiste, J ;

Nackaerts, K ;

Pinel, MIS ;

Vauthier, G ;

Younes, RN ;

Arriagada, R ;

Baeza, R ;

Carvajal, P ;

Kleinman, S ;

Orlandi, L ;

Castro, C ;

Godoy, J ;

Kosatova, K ;

Gaafar, R ;

Azarian, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360

[3]

Li QD, 1998, INT J ONCOL, V13, P987

[4] Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells [J].

Li, QD ;

Gardner, K ;

Zhang, LJ ;

Tsang, B ;

Bostick-Bruton, F ;

Reed, E .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23419-23425

[5] Divide and conquer: nucleotide excision repair battles cancer and ageing [J].

Mitchell, JR ;

Hoeijmakers, JHJ ;

Niedernhofer, LJ .

CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :232-240

[6] DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy [J].

Olaussen, Ken A. ;

Dunant, Ariane ;

Fouret, Pierre ;

Brambilla, Elisabeth ;

Andre, Fabrice ;

Haddad, Vincent ;

Taranchon, Estelle ;

Filipits, Martin ;

Pirker, Robert ;

Popper, Helmut H. ;

Stahel, Rolf ;

Sabatier, Laure ;

Pignon, Jean-Pierre ;

Tursz, Thomas ;

Le Chevalier, Thierry ;

Soria, Jean-Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :983-991

[7] ERCC1 and clinical resistance to platinum-based therapy [J].

Reed, E .

CLINICAL CANCER RESEARCH, 2005, 11 (17) :6100-6102

[8] Nucleotide excision repair and anti-cancer chemotherapy [J].

Reed, E .

CYTOTECHNOLOGY, 1998, 27 (1-3) :187-201

[9]

Sancar A, 2004, ADV PROTEIN CHEM, V69, P43

[10] ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer [J].

Viguier, J ;

Boige, V ;

Miquel, C ;

Pocard, M ;

Giraudeau, B ;

Sabourin, JC ;

Ducreux, M ;

Sarasin, A ;

Praz, F .

CLINICAL CANCER RESEARCH, 2005, 11 (17) :6212-6217

← 1 2 →